WATCH: @Dr_AmerZeidan discusses the primary end point and subgroup analyses performed on the COMMANDS trial of luspatercept for treating anemia in patients with #MDS. @SmilowCancer @YaleCancer targetedonc.com/view/subgroup-…
0
0
3
471
0